Skip to main content
Screener/Healthcare/Biotechnology

CBIO — Crescent Biopharma, Inc.

NASDAQ
$14.79-1.75 (-10.64%)
Small CapUnder $20Healthcare
$8.76
$27.41
$14.67
$16.46
EPS (TTM)$-10.91
P/E Ratio883.54
Dividend Yield—
Market Cap$627.4M
Volume139K
Prev Close$16.44
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0$0$-0.70——
Q4 '25$10.8M-$92.4M$-4.0199.5%-852.1%
Q3 '25$30.6M-$24.6M$-1.2794.7%-80.5%
Q2 '25$0-$21.8M$-4.93——
Q1 '25$0-$2.3M$-0.78——
Q4 '24$0-$7.2M$-0.92——
Q3 '24$0-$9.8M$-0.15——
Q2 '24$0-$10.1M$-0.16——
Get Your Daily Market Recap